DNA RNA and Cells

07 May 2009 Tekmira Pharmaceuticals Receives Clearance From FDA to Initiate ApoB SNALP Phase 1 Clinical Trial
07 May 2009 AMT Starts Preregistration Trial for GlyberaTM
05 May 2009 Living Cell Technologies Reports Insulin Independence in Two Patients Following Recent Implants of DIABECELL® in Diabetes Clinical Trial
01 May 2009 Isis and Collaborators Present New Research at the ATVB Annual Conference
30 Apr 2009 RXi Pharmaceuticals Announces Publication in Nature of Positive Pre-clinical Data Demonstrating that Oral Administration of RNAi Therapeutics Effectiv
29 Apr 2009 Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
29 Apr 2009 Isis and Alnylam Form New Collaboration to Develop Single-Stranded RNAi Technology
28 Apr 2009 Mesoblast Limited (ASX:MSB) Commences Clinical Program For Fusion Of Cervical Spine
28 Apr 2009 OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
28 Apr 2009 ISTO Technologies, Inc. Announces FDA Approval to Initiate a Clinical Trial for a Novel Treatment for Disc Nucleus Regeneration
27 Apr 2009 Antisense Pharma Begins Pivotal Phase III Clinical Trial with Trabedersen in Aggressive Brain Tumors
24 Apr 2009 Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies
24 Apr 2009 Argos Therapeutics Presents Research Validating Feasibility and Safety of its Arcelis Personalized Immunotherapy Platform for HIV
21 Apr 2009 Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting
17 Apr 2009 Osiris Completes Enrollment in Second Prochymal Phase III Trial for Graft vs. Host Disease
15 Apr 2009 Lorus Announces Report of Evidence of Clinical Activity in Clinical Trial of LOR-2040 Combined With Capecitabine and Oxaliplatin in the Treatment of Advanced Metastatic Solid Tumors
08 Apr 2009 Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
08 Apr 2009 The Journal of Cardiac Failure Publishes Results From Celladon Corporation's First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure
06 Apr 2009 ReNeuron announces positive pre-clinical data with lead stem cell line in peripheral arterial disease
03 Apr 2009 Alnylam Initiates Phase I Clinical Study of ALN-VSP in Patients with Liver Cancer
25 Mar 2009 Tekmira Pharmaceuticals Extends Research Collaboration With Bristol-Myers Squibb Through 2009
24 Mar 2009 Rexahn Pharmaceuticals, Inc. (RNN) Initiates Phase II Pancreatic Cancer Clinical Trial
23 Mar 2009 MDRNA Announces Worldwide Non-Exclusive Licensing Agreement for RNAi Delivery Technology
20 Mar 2009 Another LNA-based RNA Inhibitor Enters Clinical Trials

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up